Clinical Strategies Targeting the Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma

Pancreatic cancer has a complex tumor microenvironment which engages in extensive crosstalk between cancer cells, cancer-associated fibroblasts, and immune cells. Many of these interactions contribute to tumor resistance to anti-cancer therapies. Here, new therapeutic strategies designed to modulate...

Full description

Bibliographic Details
Main Authors: Nebojsa Skorupan, Mayrel Palestino Dominguez, Samuel L. Ricci, Christine Alewine
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/14/17/4209
_version_ 1797496082217828352
author Nebojsa Skorupan
Mayrel Palestino Dominguez
Samuel L. Ricci
Christine Alewine
author_facet Nebojsa Skorupan
Mayrel Palestino Dominguez
Samuel L. Ricci
Christine Alewine
author_sort Nebojsa Skorupan
collection DOAJ
description Pancreatic cancer has a complex tumor microenvironment which engages in extensive crosstalk between cancer cells, cancer-associated fibroblasts, and immune cells. Many of these interactions contribute to tumor resistance to anti-cancer therapies. Here, new therapeutic strategies designed to modulate the cancer-associated fibroblast and immune compartments of pancreatic ductal adenocarcinomas are described and clinical trials of novel therapeutics are discussed. Continued advances in our understanding of the pancreatic cancer tumor microenvironment are generating stromal and immune-modulating therapeutics that may improve patient responses to anti-tumor treatment.
first_indexed 2024-03-10T01:58:35Z
format Article
id doaj.art-1fbbfaf616b14bc993383750c4b42bbd
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T01:58:35Z
publishDate 2022-08-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-1fbbfaf616b14bc993383750c4b42bbd2023-11-23T12:51:49ZengMDPI AGCancers2072-66942022-08-011417420910.3390/cancers14174209Clinical Strategies Targeting the Tumor Microenvironment of Pancreatic Ductal AdenocarcinomaNebojsa Skorupan0Mayrel Palestino Dominguez1Samuel L. Ricci2Christine Alewine3Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USALaboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USALaboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USALaboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USAPancreatic cancer has a complex tumor microenvironment which engages in extensive crosstalk between cancer cells, cancer-associated fibroblasts, and immune cells. Many of these interactions contribute to tumor resistance to anti-cancer therapies. Here, new therapeutic strategies designed to modulate the cancer-associated fibroblast and immune compartments of pancreatic ductal adenocarcinomas are described and clinical trials of novel therapeutics are discussed. Continued advances in our understanding of the pancreatic cancer tumor microenvironment are generating stromal and immune-modulating therapeutics that may improve patient responses to anti-tumor treatment.https://www.mdpi.com/2072-6694/14/17/4209immunotherapypancreatic cancerstromal modifierscancer-associated fibroblasts
spellingShingle Nebojsa Skorupan
Mayrel Palestino Dominguez
Samuel L. Ricci
Christine Alewine
Clinical Strategies Targeting the Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma
Cancers
immunotherapy
pancreatic cancer
stromal modifiers
cancer-associated fibroblasts
title Clinical Strategies Targeting the Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma
title_full Clinical Strategies Targeting the Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma
title_fullStr Clinical Strategies Targeting the Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma
title_full_unstemmed Clinical Strategies Targeting the Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma
title_short Clinical Strategies Targeting the Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma
title_sort clinical strategies targeting the tumor microenvironment of pancreatic ductal adenocarcinoma
topic immunotherapy
pancreatic cancer
stromal modifiers
cancer-associated fibroblasts
url https://www.mdpi.com/2072-6694/14/17/4209
work_keys_str_mv AT nebojsaskorupan clinicalstrategiestargetingthetumormicroenvironmentofpancreaticductaladenocarcinoma
AT mayrelpalestinodominguez clinicalstrategiestargetingthetumormicroenvironmentofpancreaticductaladenocarcinoma
AT samuellricci clinicalstrategiestargetingthetumormicroenvironmentofpancreaticductaladenocarcinoma
AT christinealewine clinicalstrategiestargetingthetumormicroenvironmentofpancreaticductaladenocarcinoma